MedDataX Logo

Ultrasound Diagnosis of Antibiotic Associated Diarrhea

NCT ID: NCT00658151

Last Updated: 2008-04-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The hypothesis is that there are unique sonographic characteristics of antibiotic-associated diarrhea. We will compare the ultrasound findings in patients who received antibiotics and developed diarrhea to toxin analysis for clostridium difficile in stool in order to find differences in the sonographic findings in the positive and negative cases.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Antibiotic-Associated Diarrhea

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

focus study evaluate sonographic findings colon patients developed

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* admitted patients who developed diarrhea in 72 hours since the beginning of admission
* patients age above 18 years.
* patients received antibiotics during admission

Exclusion Criteria

* other reasons of diarrhea
* drugs induced diarrhea
* length of time since the beginning of diarrhea is shorter than 72 hours.
* patients had diarrhea during the first day of admission
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shaare Zedek Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Shaare Zedek Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Shaare Zedek Medical Center

Jerusalem, , Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Michael Avital, doctor

Role: CONTACT

Phone: 9727727340

Email: [email protected]

Yonit Veiner, doctor

Role: CONTACT

Phone: 9728687373

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

avital.ctil

Identifier Type: -

Identifier Source: org_study_id